Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 2
1991 3
1992 6
1993 1
1994 1
1995 5
1996 1
1997 5
1998 1
1999 4
2002 1
2003 1
2004 3
2005 1
2006 3
2008 3
2009 1
2011 1
2012 1
2014 1
2020 1
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Challenges in treating liver fibrosis.
Poo JL, Muñoz LE. Poo JL, et al. Ann Hepatol. 2014 Nov-Dec;13(6):845-6. Ann Hepatol. 2014. PMID: 25332275 Free article. No abstract available.
Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy.
Sansores RH, Ramírez-Venegas A, Montiel-Lopez F, Domínguez-Arellano S, Alva-Lopez LF, Falfán-Valencia R, Pérez-Rubio G, Olaya-López E, Zavaleta-Martínez EO, Aguilar-Medina S, Escobar-Alvarado JC, Poo JL, Matera MG, Cazzola M. Sansores RH, et al. Among authors: poo jl. Respir Med. 2023 Oct;217:107362. doi: 10.1016/j.rmed.2023.107362. Epub 2023 Jul 13. Respir Med. 2023. PMID: 37451648 Clinical Trial.
Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study.
Poo JL, Aguilar JR, Bernal-Reyes R, Alonso-Campero R, Gasca F, Hernández L, Pineyro-Garza E, Gomez-Silva M, Gamino ME, la Parra MG, Peña P, Hernández N, Tapia G, Muñoz-Espinosa LE. Poo JL, et al. Biomed Pharmacother. 2023 Dec;168:115712. doi: 10.1016/j.biopha.2023.115712. Epub 2023 Oct 21. Biomed Pharmacother. 2023. PMID: 37871556 Free article.
[Advances in hepatology 1990].
Uribe M, Poo JL. Uribe M, et al. Among authors: poo jl. Rev Invest Clin. 1990 Jul;42 Suppl:1-2. Rev Invest Clin. 1990. PMID: 19256124 Spanish. No abstract available.
Etiology of liver cirrhosis in Mexico.
Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juórez A, Castñeda B, Sánchez-Avila F, Poo JL, Guevara González L, Lizardi J, Valdovinos MA, Uribe M, Contreras AM, Tirado P, Aguirre J, Rivera-Benítez C, Santiago-Santiago R, Bosques-Padilla F, Muñoz L, Guerroro A, Ramos M, Rodríguez-Hernández H, Jacobo-Karam J; Grupo de Estudio, Asociación Mexicana de Hepatología. Méndez-Sánchez N, et al. Among authors: poo jl. Ann Hepatol. 2004 Jan-Mar;3(1):30-3. Ann Hepatol. 2004. PMID: 15118577 Free article.
Effect of Prolonged-Release Pirfenidone on Renal Function in Septic Acute Kidney Injury Patients: A Double-Blind Placebo-Controlled Clinical Trial.
Chávez-Iñiguez JS, Poo JL, Ibarra-Estrada M, García-Benavides L, Navarro-Blackaller G, Cervantes-Sánchez C, Nungaray-Pacheco E, Medina-González R, Armendariz-Borunda J, García-García G. Chávez-Iñiguez JS, et al. Among authors: poo jl. Int J Nephrol. 2021 Jan 13;2021:8833278. doi: 10.1155/2021/8833278. eCollection 2021. Int J Nephrol. 2021. PMID: 33520317 Free PMC article.
50 results